Growth Metrics

Incyte (INCY) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -13.32%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 17.12%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -10.19%
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 24.11%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 12.18%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 3.92%
10 Incyte 19.28 Bn 15.27 Bn 1.17 Bn -5.90%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5.90%
Dec 31, 2025 -4.26%
Sep 30, 2025 3.30%
Jun 30, 2025 4.79%
Mar 31, 2025 6.30%
Dec 31, 2024 1.58%
Sep 30, 2024 5.46%
Jun 30, 2024 1.69%
Mar 31, 2024 -2.93%
Dec 31, 2023 1.65%
Sep 30, 2023 2.42%
Jun 30, 2023 3.89%
Mar 31, 2023 1.71%
Dec 31, 2022 2.13%
Sep 30, 2022 4.23%
Jun 30, 2022 9.07%
Mar 31, 2022 22.63%
Dec 31, 2021 29.36%
Sep 30, 2021 37.80%
Jun 30, 2021 45.75%
Mar 31, 2021 45.03%
Dec 31, 2020 48.22%
Jun 30, 2020 33.81%
Mar 31, 2020 21.19%
Dec 31, 2019 18.08%
Jun 30, 2019 26.73%
Mar 31, 2019 27.86%
Dec 31, 2018 23.09%
Sep 30, 2018 21.85%
Jun 30, 2018 22.25%
Mar 31, 2018 36.95%
Dec 31, 2017 54.92%
Sep 30, 2017 62.45%
Jun 30, 2017 58.02%
Mar 31, 2017 108.60%
Dec 31, 2016 94.96%
Sep 30, 2016 82.65%
Jun 30, 2016 69.74%
Mar 31, 2016 14.82%
Dec 31, 2015 5.15%
Sep 30, 2015 10.53%
Jun 30, 2015 46.75%
Mar 31, 2015 108.69%
Dec 31, 2014 204.64%
Sep 30, 2014 1,113.64%
Jun 30, 2014 791.71%
Mar 31, 2014 496.05%
Dec 31, 2013 322.94%
Sep 30, 2013 0.52%
Jun 30, 2013 -4.28%
Mar 31, 2013 4.06%
Dec 31, 2012 -1.29%
Sep 30, 2012 1.51%
Jun 30, 2012 18.45%
Mar 31, 2012 26.31%
Dec 31, 2011 33.87%